FREQ Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Notice: This stock is marked as potentially delisted. It may not be actively trading.

Insider Ownership Percentage: 16.80%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Frequency Therapeutics Insider Trading History Chart

Frequency Therapeutics Share Price & Price History

^$0.30

+0.30 (1.20%)

As of 11/3/2023 01:00 AM ET

Frequency Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/18/2023	David L Lucchino	CEO	Sell	2,865	$0.60	$1,719.00	636,801
8/18/2023	Richard J Mitrano	VP	Sell	227	$0.63	$143.01	48,694
8/16/2023	David L Lucchino	CEO	Sell	2,895	$0.65	$1,881.75	642,399
8/16/2023	Richard J Mitrano	VP	Sell	234	$0.67	$156.78	49,151
8/14/2023	David L Lucchino	CEO	Sell	2,881	$0.63	$1,815.03	647,923
8/14/2023	Richard J Mitrano	VP	Sell	238	$0.64	$152.32	49,613
8/10/2023	David L Lucchino	CEO	Sell	2,790	$0.68	$1,897.20	653,537
8/10/2023	Richard J Mitrano	VP	Sell	247	$0.64	$158.08	50,091
8/7/2023	David L Lucchino	CEO	Sell	2,857	$0.68	$1,942.76	661,935
8/7/2023	Richard J Mitrano	VP	Sell	235	$0.69	$162.15	50,817
8/4/2023	David L Lucchino	CEO	Sell	2,550	$0.69	$1,759.50	664,792
8/4/2023	Richard J Mitrano	VP	Sell	220	$0.67	$147.40	51,052
8/2/2023	David L Lucchino	CEO	Sell	2,587	$0.52	$1,345.24	670,021
8/2/2023	Richard J Mitrano	VP	Sell	231	$0.49	$113.19	51,504
7/31/2023	David L Lucchino	CEO	Sell	2,676	$0.50	$1,338.00	675,407
7/31/2023	Richard J Mitrano	VP	Sell	222	$0.50	$111.00	51,973
7/28/2023	Christopher R. Loose	Insider	Sell	1,344	$0.46	$618.24	183,650
7/28/2023	David L Lucchino	CEO	Sell	2,647	$0.47	$1,244.09	678,083
7/28/2023	Richard J Mitrano	VP	Sell	223	$0.47	$104.81	52,195
7/26/2023	Christopher R. Loose	Insider	Sell	1,329	$0.51	$677.79	186,367
7/26/2023	David L Lucchino	CEO	Sell	2,609	$0.52	$1,356.68	683,521
7/26/2023	Richard J Mitrano	VP	Sell	222	$0.53	$117.66	52,645
7/24/2023	Christopher R. Loose	Insider	Sell	1,438	$0.54	$776.52	189,086
7/24/2023	David L Lucchino	CEO	Sell	2,887	$0.54	$1,558.98	688,933
7/24/2023	Richard J Mitrano	VP	Sell	234	$0.56	$131.04	53,101
7/21/2023	Christopher R. Loose	Insider	Sell	1,333	$0.61	$813.13	190,524
7/21/2023	David L Lucchino	CEO	Sell	2,663	$0.61	$1,624.43	691,820
7/21/2023	Richard J Mitrano	VP	Sell	223	$0.61	$136.03	53,335
7/19/2023	Christopher R. Loose	Insider	Sell	1,335	$0.65	$867.75	193,218
7/19/2023	David L Lucchino	CEO	Sell	2,646	$0.65	$1,719.90	697,193
7/19/2023	Richard J Mitrano	VP	Sell	228	$0.63	$143.64	53,787
7/17/2023	Christopher R. Loose	Insider	Sell	1,415	$0.67	$948.05	196,037
7/17/2023	David L Lucchino	CEO	Sell	2,775	$0.68	$1,887.00	702,807
7/17/2023	Richard J Mitrano	VP	Sell	244	$0.65	$158.60	54,264
7/14/2023	Christopher R. Loose	Insider	Sell	906	$0.59	$534.54	197,452
7/14/2023	David L Lucchino	CEO	Sell	1,815	$0.59	$1,070.85	705,582
7/14/2023	Richard J Mitrano	VP	Sell	148	$0.60	$88.80	54,508
7/12/2023	Christopher R. Loose	Insider	Sell	1,335	$0.39	$520.65	199,687
7/12/2023	David L Lucchino	CEO	Sell	2,649	$0.39	$1,033.11	710,043
7/12/2023	Richard J Mitrano	VP	Sell	220	$0.40	$88.00	54,883
7/10/2023	Christopher R. Loose	Insider	Sell	1,304	$0.37	$482.48	66,023
7/10/2023	David L Lucchino	CEO	Sell	2,591	$0.38	$984.58	442,696
7/10/2023	Richard J Mitrano	VP	Sell	220	$0.37	$81.40	32,605
7/6/2023	Christopher R. Loose	Insider	Sell	1,384	$0.34	$470.56	57,758
7/6/2023	David L Lucchino	CEO	Sell	2,773	$0.34	$942.82	429,739
7/6/2023	Richard J Mitrano	VP	Sell	224	$0.35	$78.40	31,529

SEC Filings (Institutional Ownership Changes) for Frequency Therapeutics (NASDAQ:FREQ)

13.18% of Frequency Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Frequency Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/15/2023	Adage Capital Partners GP L.L.C.	1,200,000	$0.44M	0.0%	N/A	3.286%
11/14/2023	Eventide Asset Management LLC	3,597,122	$1.33M	0.0%	N/A	9.850%
2/13/2023	GSA Capital Partners LLP	264,728	$1.02M	0.1%	+7.3%	0.751%
2/8/2023	Belpointe Asset Management LLC	9,675	$37K	0.0%	N/A	0.027%
1/25/2023	Duncker Streett & Co. Inc.	14,355	$55K	0.0%	N/A	0.041%
11/15/2022	Federated Hermes Inc.	1,324,018	$2.37M	0.0%	-14.7%	3.755%
11/14/2022	Ergoteles LLC	117,744	$0.21M	0.0%	-24.7%	0.334%
11/14/2022	Brown Advisory Inc.	19,795	$35K	0.0%	N/A	0.056%
9/16/2022	Federated Hermes Inc.	1,551,680	$2.33M	0.0%	-47.7%	4.400%
8/3/2022	Waldron Private Wealth LLC	70,670	$0.11M	0.0%	N/A	0.202%
8/2/2022	Centaurus Financial Inc.	22,100	$33K	0.0%	+118.8%	0.063%
8/1/2022	Essex Financial Services Inc.	20,000	$30K	0.0%	N/A	0.057%
5/12/2022	Northeast Financial Consultants Inc	45,826	$97K	0.0%	+189.6%	0.131%
5/12/2022	Connor Clark & Lunn Investment Management Ltd.	61,985	$0.13M	0.0%	N/A	0.177%
5/11/2022	GSA Capital Partners LLP	301,510	$0.64M	0.1%	+37.1%	0.862%
5/10/2022	South Dakota Investment Council	95,056	$0.20M	0.0%	-86.7%	0.272%
5/9/2022	Duncker Streett & Co. Inc.	15,766	$33K	0.0%	N/A	0.045%
5/6/2022	Tortoise Investment Management LLC	12,683	$27K	0.0%	N/A	0.036%
5/3/2022	North Star Investment Management Corp.	60,000	$0.13M	0.0%	N/A	0.172%
5/2/2022	Allspring Global Investments Holdings LLC	25,853	$54K	0.0%	N/A	0.074%
3/3/2022	Walleye Capital LLC	146,208	$0.75M	0.0%	+21.8%	0.423%
2/16/2022	Wasatch Advisors Inc.	3,166,962	$16.25M	0.1%	-1.9%	9.153%
2/14/2022	Lombard Odier Asset Management Switzerland SA	707,071	$3.63M	0.2%	+9.2%	2.043%
2/14/2022	PDT Partners LLC	44,932	$0.23M	0.0%	-46.5%	0.130%
2/14/2022	GSA Capital Partners LLP	219,932	$1.13M	0.1%	+169.4%	0.636%
2/11/2022	Northeast Financial Consultants Inc	15,826	$81K	0.0%	-61.7%	0.046%
2/8/2022	Northern Trust Corp	286,839	$1.47M	0.0%	-22.6%	0.829%
2/7/2022	SG Americas Securities LLC	10,137	$52K	0.0%	-53.6%	0.029%
2/3/2022	Advisor Group Holdings Inc.	10,900	$56K	0.0%	-26.4%	0.032%
11/16/2021	Two Sigma Advisers LP	182,200	$1.29M	0.0%	+11.0%	0.529%
11/16/2021	Two Sigma Investments LP	251,610	$1.78M	0.0%	-3.7%	0.731%
11/16/2021	Voloridge Investment Management LLC	165,622	$1.17M	0.0%	-33.0%	0.481%
11/16/2021	Laurion Capital Management LP	69,348	$0.49M	0.0%	-29.7%	0.201%
11/15/2021	California State Teachers Retirement System	36,926	$0.26M	0.0%	-16.4%	0.107%
11/15/2021	Granahan Investment Management Inc. MA	43,030	$0.30M	0.0%	-66.2%	0.125%
11/15/2021	Neuberger Berman Group LLC	55,801	$0.39M	0.0%	-3.0%	0.162%
11/15/2021	Franklin Resources Inc.	10,347	$73K	0.0%	N/A	0.030%
11/15/2021	GSA Capital Partners LLP	81,652	$0.58M	0.1%	N/A	0.237%
11/15/2021	Lombard Odier Asset Management Switzerland SA	647,265	$4.57M	0.3%	+8.5%	1.881%
11/12/2021	Wasatch Advisors Inc.	3,228,184	$22.79M	0.1%	-3.1%	9.380%
11/12/2021	Geode Capital Management LLC	536,012	$3.78M	0.0%	-1.9%	1.557%
11/10/2021	Goldman Sachs Group Inc.	135,692	$0.96M	0.0%	+61.4%	0.394%
11/10/2021	Citigroup Inc.	5,878	$41K	0.0%	-54.7%	0.017%
11/9/2021	South Dakota Investment Council	716,726	$5.06M	0.1%	+10.0%	2.082%
11/9/2021	BlackRock Inc.	3,191,851	$22.54M	0.0%	+3.9%	9.274%
11/5/2021	Advisor Group Holdings Inc.	14,805	$0.10M	0.0%	-76.0%	0.043%
11/4/2021	Deutsche Bank AG	23,496	$0.17M	0.0%	-7.0%	0.068%
11/2/2021	EMC Capital Management	27,029	$0.17M	0.1%	N/A	0.079%
11/2/2021	New York State Common Retirement Fund	19,117	$0.14M	0.0%	-31.2%	0.056%
11/1/2021	SG Americas Securities LLC	21,851	$0.15M	0.0%	N/A	0.063%
10/28/2021	WINTON GROUP Ltd	20,918	$0.15M	0.0%	+46.7%	0.061%
10/25/2021	Jaffetilchin Investment Partners LLC	26,150	$0.19M	0.0%	-41.1%	0.076%
9/3/2021	Parametric Portfolio Associates LLC	46,139	$0.46M	0.0%	+319.8%	0.134%

Data available starting January 2016

Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules to activate progenitor cells within the body to create functional tissue. The company's lead product candidate is FX-322, which is in Phase IIb clinical trial to treat the underlying cause of sensorineural hearing loss. It is also developing medicines for patients across a range of degenerative conditions, including multiple sclerosis, and diseases of the muscle, gastrointestinal tract, skin, and bone. The company has a license and collaboration agreement with Astellas Pharma Inc. for the development and commercialization of FX-322, as well as collaboration and licensing agreements with Massachusetts Eye and Ear, the Massachusetts Institute of Technology, and The Scripps Research Institute. Frequency Therapeutics, Inc. was incorporated in 2014 and is headquartered in Lexington, Massachusetts.

Today's Range

Now: $0.30

$0.28

$0.32

50 Day Range

MA: $0.58

$0.22

$14.98

52 Week Range

Now: $0.30

$0.18

$16.00

Volume

309,164 shs

Average Volume

822,537 shs

Market Capitalization

$10.94 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.84